Stoke Therapeutics (STOK) Insider Trading & Ownership $9.76 -0.12 (-1.21%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$9.76 0.00 (0.00%) As of 04/25/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Stoke Therapeutics (NASDAQ:STOK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$28.31 M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STOK Insider Buying and Selling by Quarter Stoke Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2025Barry TichoInsiderSell3,884$8.67$33,674.28 3/18/2025Edward M Md KayeDirectorSell10,382$8.67$90,011.94 3/18/2025Jonathan AllanGeneral CounselSell2,266$8.67$19,646.22 12/9/2024Barry TichoInsiderSell2,586$12.99$33,592.14 12/9/2024Edward M Md KayeCEOSell6,786$12.99$88,150.14 12/9/2024Jonathan AllanGeneral CounselSell13,666$13.61$185,994.26 12/6/2024Barry TichoInsiderSell13,945$12.78$178,217.10 12/6/2024Edward M Md KayeCEOSell6,170$12.78$78,852.60 12/6/2024Jonathan AllanGeneral CounselSell9,696$12.78$123,914.88 12/2/2024Barry TichoInsiderSell10,000$12.07$120,700.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/19/2024Skorpios TrustMajor ShareholderSell1,937,500$14.05$27,221,875.00 7/1/2024Barry TichoInsiderSell10,000$13.75$137,500.00 (Data available from 1/1/2013 forward) STOK Insider Trading Activity - Frequently Asked Questions Who is on Stoke Therapeutics's Insider Roster? The list of insiders at Stoke Therapeutics includes Barry Ticho, Edward M Md Kaye, Jonathan Allan, Skorpios Trust, and Stephen J Tulipano. Learn more on insiders at STOK. What percentage of Stoke Therapeutics stock is owned by insiders? 11.30% of Stoke Therapeutics stock is owned by insiders. Learn more on STOK's insider holdings. Which Stoke Therapeutics insiders have been selling company stock? The following insiders have sold STOK shares in the last 24 months: Barry Ticho ($1,435,131.10), Edward M Md Kaye ($325,029.68), Jonathan Allan ($437,806.50), Skorpios Trust ($68,981,875.00), and Stephen J Tulipano ($25,107.60). How much insider selling is happening at Stoke Therapeutics? Insiders have sold a total of 5,751,234 Stoke Therapeutics shares in the last 24 months for a total of $71,204,949.88 sold. Stoke Therapeutics Key ExecutivesDr. Edward M. Kaye M.D. (Age 75)Ph.D., CEO & Director Compensation: $948.9kDr. Adrian R. Krainer Ph.D. (Age 65)Co-Founder & Independent Director Compensation: $44kDr. Barry S. Ticho FACC (Age 63)M.D., Ph.D., Chief Medical Officer Compensation: $684.55kMs. Isabel Aznarez Ph.D. (Age 51)Co-Founder & Group VP of Discovery Research Mr. Thomas Edward Leggett (Age 47)Chief Financial Officer Dr. Huw M. Nash Ph.D. (Age 57)COO & Chief Business Officer Compensation: $429.67kMr. Eric RojasHead of Investor RelationsMr. Jonathan Allan J.D. (Age 34)Corporate Secretary & General Counsel 3 recent tradesMs. Dawn Kalmar (Age 46)Chief Communications Officer Ms. Joan WoodChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies TARS Insider Trades GMTX Insider Trades BEAM Insider Trades NAMS Insider Trades KYMR Insider Trades BHC Insider Trades JANX Insider Trades ARWR Insider Trades HRMY Insider Trades CNTA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:STOK) was last updated on 4/28/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
